Live Quote · OTCSFOSFHealthcare · Drug Manufacturers - Specialty & Generic

Shanghai Fosun Pharmaceutical (Group) Co., Ltd.

$2.02▲ 0.00%(+$0.00)

TickerSpark Score

62/100

▌ Mixed

90

Valuation

65

Profitability

55

Growth

68

Health

30

Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a SFOSF research report →

52-Week Range4% of range

Low

$1.96

Current

$2.02

High

$3.50

Company Overviewwww.fosunpharma.com

About the company

Shanghai Fosun Pharmaceutical (Group) Co. , Ltd. (SFOSF), founded in 1994 and based in Shanghai, China, is a comprehensive pharmaceutical enterprise.

CEO: Yi Liu
IPO: 2014
Employees: 40,557
HQ: Shanghai, CN

Price Chart

+3.06% · this period

Valuation

Market Cap: $5.35B
P/E: 17.68
P/S: 1.45
P/B: 1.25
EV/EBITDA: 11.75
Div Yield: 1.37%

Profitability

Gross Margin: 49.44%
Op Margin: 9.63%
Net Margin: 8.22%
ROE: 7.19%
ROIC: 3.15%

Growth & Income

Revenue: $40.43B · -1.56%
Net Income: $3.28B · 18.55%
EPS: $1.26 · 21.15%
Op Income: $2.54B
FCF YoY: 1045.04%

Performance & Tape

52W High: $3.50
52W Low: $1.96
50D MA: $2.29
200D MA: $2.78
Beta: 0.35
Avg Volume: 124

Get TickerSpark's AI analysis on SFOSF

Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

Already have an account? Log in

Coverage · SFOSF